HT-29/iRFP stable cell line

HT-29/iRFP cells are derived from the human colon cancer cell line HT-29 by stably integration of a constitutive miRFP670 stably expression construct. HT-29 cell line has been widely used to study molecular mechanism under cancer development, including tumor growth, invasion, and metastasis, as well as identify potential therapeutic targets. HT-29/iRFP cells stably express miRFP670, can be used for in vitro assays and in vivo imaging.